Germinal centers (GCs) are microanatomically defined structures that arise in lymphoid tissues during the immune response ([@bib26]; [@bib37]). They are composed of B cells undergoing rapid clonal expansion and selection, cognate follicular helper T cells, follicular dendritic cells that capture and retain antigen on their surface, and a small number of conventional dendritic cells ([@bib26]; [@bib37]; [@bib24]; [@bib22]). The GC reaction is of significant interest because it is the primary source of the somatically hypermutated, high-affinity antibodies that underlie immunity and autoimmunity. Most studies of how high-affinity antibodies are formed focus exclusively on the GC reaction because of its distinct anatomical, cellular, and molecular features. However, between the first contact with foreign antigen and the establishment of the GC, activated B cells progress through a series of distinct steps ([@bib33]), all or any of which could potentially impact affinity-based selection.

B cells come into contact with soluble antigen directly in B cell follicles ([@bib30]). In addition, B cells can also acquire antigen bound to other lymph node--resident cell types, such as subcapsular macrophages ([@bib6]; [@bib19]; [@bib34]), follicular dendritic cells ([@bib49]), and lymphoid dendritic cells, both in the periphery of high-endothelial venules ([@bib35]) and in the lymph node medulla ([@bib13]). After the initial contact with antigen, B cells travel to the border between the T cell zone and B cell follicle (T--B border) where they interact with cognate T cells to form antigen-specific cell clusters ([@bib25]; [@bib12]; [@bib38]; [@bib29]). After leaving T--B border clusters, B cells concentrate in the outer follicle in lymph nodes or in the area adjacent to the marginal zone in the spleen ([@bib7]; [@bib33]), where they proliferate for a brief period before entering the GC reaction or developing into short-lived plasmablasts. Although the precise nature of the signals that govern this key cell fate decision is not entirely understood, high-affinity BCR cross-linking is thought to favor the plasmablast response ([@bib32]). However, B cell autonomous signals alone may not be sufficient to determine B cell fate decision. In particular, cognate B and T cells in T--B border clusters engage in long-lived, dynamic contacts ([@bib29]; [@bib36]), which could also help direct B cells to either the GC or early antibody-forming cell fates.

Whereas GC competition and affinity maturation have been studied extensively, less is known about how antibody affinity impacts the initial selection of B cells into the GC. In this study, we make use of multiphoton intravital imaging to examine the initial events that mediate B cell selection into the GC reaction. We find that antibody affinity regulates pre-GC competition and that this process is mediated by B cell presentation of cognate antigen to T cells.

RESULTS
=======

GC seeding is dependent on interclonal competition
--------------------------------------------------

To examine the role of affinity in B cell selection into the GC reaction, we made use of two strains of knockin mice carrying *Ig* heavy chains that, when combined with an Igλ light chain, produce antibodies with different affinities for the hapten 4-hydroxy-3-nitrophenylacetyl (NP; [@bib48]). High-affinity B1-8^hi^ B cells have a 40-fold higher affinity (*K*~a~ 5 × 10^6^ M^−1^; *K*~d~ 2 × 10^−7^ M) for NP than low-affinity B1-8^lo^ B cells (*K*~a~ 1.25 × 10^5^ M^−1^; *K*~d~ 8 × 10^−6^ M), and WT B cells bearing native B1-8 (VH186.2, DFL16.1, and JH2) antibody genes are of intermediate affinity (*K*~a~ 5 × 10^5^ M^−1^; *K*~d~ 2 × 10^−6^ M; [@bib2]).

B1-8^hi^ and B1-8^lo^ cells produce comparable NP-specific GCs in response to antigen when in a noncompetitive environment ([@bib47]). B1-8^hi^ cells also predominate in the GC when transferred into the competitive environment of a WT recipient ([@bib44], [@bib45]). In contrast to high-affinity B cells, low-affinity B1-8^lo^ cells transferred into WT recipients were unable to compete with endogenous polyclonal B cells and accounted for only a fraction of total GC cells ([Fig. 1, A--C](#fig1){ref-type="fig"}). Thus, the relative affinity of the BCR determines whether a B cell will dominate the GC reaction.

![**GC occupancy is regulated by competition.** (A) Diagrammatic representation of the experimental protocol. (B) Histology showing composition of GCs in draining lymph nodes 6 d after immunization. B1-8^lo^ B cells are GFP^+^ (false-colored red), and B1-8^hi^ B cells are CD45.1^+^ (green). GCs were identified by absence of IgD^+^ B cells (blue) within the B cell follicle. Images are representative of multiple GCs from two independent experiments. (C) Composition of GCs by flow cytometry. Gated on CD19^+^Igλ^+^FAS^+^GL-7^+^. (left) Representative flow cytometry plots showing the fraction of cells of each genotype (B1-8^lo^ B cells are CFP^+^, B1-8^hi^ B cells are CD45.1^+^, and endogenous B cells are CFP^−^CD45.1^−^). (right) Quantification of GC occupancy under different conditions. Each symbol represents one mouse. Data are from two independent experiments with two to three mice per condition per experiment.](JEM_20102477_RGB_Fig1){#fig1}

To further investigate the nature of the competition, we transferred B1-8^lo^ B cells alone or in combination with competing B1-8^hi^ B cells into hosts with a limited BCR repertoire (MD4 mice; [Fig. 1 A](#fig1){ref-type="fig"}). MD4 recipients are transgenic for an Ig that is specific for hen egg lysozyme, and ∼99% of B cells in these mice express the transgenic BCR ([@bib14]). Thus, although MD4 recipients are B cell sufficient, there are very few if any endogenous NP-specific B cells that might compete with transferred B1-8^hi^ or B1-8^lo^ cells for NP binding ([Fig. S1](http://www.jem.org/cgi/content/full/jem.20102477/DC1)). OT-II T cells were cotransferred with B cells to normalize T cell help between WT and transgenic hosts. As expected, transfer into this noncompetitive environment rescued the ability of B1-8^lo^ cells to dominate the GC reaction ([Fig. 1, B and C](#fig1){ref-type="fig"}). In contrast, when B1-8^lo^ cells were cotransferred into MD4 mice with B1-8^hi^, GCs were composed almost entirely of B1-8^hi^ cells ([Fig. 1 B](#fig1){ref-type="fig"}). Quantitative analysis by flow cytometry showed a dramatic decrease in the proportion of B1-8^lo^ B cells in GCs, from 89 to 1%, in the presence of B1-8^hi^ B cells ([Fig. 1 C](#fig1){ref-type="fig"}). We conclude that a B cell clone's ability to emerge in the GC is restrained by interclonal competition.

Competition inhibits B cell proliferation and activation before GC coalescence
------------------------------------------------------------------------------

B1-8^hi^ cells dominate GCs as early as day 6 after immunization, even in the presence of large numbers of B1-8^lo^ naive precursors, suggesting that competitive selection might occur even before GCs are fully established. To investigate this possibility, we examined B cells responding to NP on day 4 after immunization ([Fig. 2](#fig2){ref-type="fig"}), before GCs can be detected by histology or flow cytometry ([Fig. S2](http://www.jem.org/cgi/content/full/jem.20102477/DC1)). On day 4 after independent transfer into MD4 mice and challenge with cognate antigen, both B1-8^hi^ and B1-8^lo^ B cells divided extensively and began to up-regulate activation markers, some of which are associated with the GC (FAS and GL-7 antigen; [Fig. 2](#fig2){ref-type="fig"} and Fig. S2). However, these early responding B cells were phenotypically distinct from authentic GC cells because they remained IgD^+^ and expressed high levels of the chemokine receptor CCR6 (Fig. S2). Thus, FAS^int^GL-7^+^IgD^+^CCR6^hi^ B cells represent a transitional stage between naive and GC B cell phenotypes (pre-GC B cells).

![**Competition inhibits early proliferation and activation of low-affinity B cells.** (A) Diagrammatic representation of the experimental protocol. (B) Flow cytometric analysis of transferred B1-8^lo^ CD45.1^+^ CFSE-labeled B cells in draining lymph nodes 4 d after immunization. Gated on CD19^+^Igλ^+^CD45.1^+^ cells. (top) Representative CFSE dilution histograms. (bottom) Representative FAS/GL-7 dot plots. (C) Quantification of B. (left) Percentage of divided (CFSE^low^) B1-8^lo^ B cells. (right) Percentage of FAS^int^GL-7^+^ B1-8^lo^ cells. Each symbol represents one mouse. Error bars are SEM. Data are from three independent experiments with one to three mice per condition per experiment. \*\*, P \< 0.01; \*\*\*, P \< 0.001 compared with B1-8^lo^ in MD4 host.](JEM_20102477_GS_Fig2){#fig2}

To determine whether affinity-dependent competition occurs before GC formation, we transferred B1-8^lo^ B cells with or without B1-8^hi^ into MD4 or WT hosts and measured proliferation by CFSE dilution on day 4 after immunization ([Fig. 2 A](#fig2){ref-type="fig"}). Although proliferation was readily detected when B1-8^lo^ cells were transferred alone (mean 72% CFSE^low^), cotransfer of B1-8^hi^ cells at a 1:1 ratio inhibited B1-8^lo^ proliferation (mean 42% CFSE^low^). Cotransfer of a threefold excess of B1-8^hi^ B cells caused a further drop in CFSE^low^ cells to 26% ([Fig. 2, B and C](#fig2){ref-type="fig"}). Similarly, the proportion of pre-GC B1-8^lo^ B cells decreased from 61% when B1-8^lo^ were transferred alone to 15% and 4% when cotransferred with B1-8^hi^ at 1:1 and 1:3 ratios, respectively ([Fig. 2, B and C](#fig2){ref-type="fig"}). Competition between B1-8^lo^ B cells and the endogenous NP-specific repertoire in WT recipients resulted in an intermediate degree of inhibition of proliferation and activation compared with transfer into MD4 mice ([Fig. 2, B and C](#fig2){ref-type="fig"}). We conclude that affinity-based competition between B cells occurs before GCs are established and that NP-specific precursor frequency is an important factor in determining the outcome of competition.

Antigen binding and presentation are not inhibited by competition
-----------------------------------------------------------------

The affinity-based inhibition of proliferation and activation detected early in GC B cell differentiation implies that antigen-specific B cells are competing for access to a limiting factor. A potential factor limiting this differentiation could be antigen availability. To determine whether the presence of competing B cells alters the amount of antigen bound or presented by B1-8^lo^ B cells, we generated a chimeric antigen consisting of streptavidin (SA) covalently coupled to both NP and Alexa Fluor 647 (a pH-insensitive fluorophore) and bound to biotinylated I-Eα~52--73~ peptide (NP-Eα; [Fig. S3 A](http://www.jem.org/cgi/content/full/jem.20102477/DC1)). This reagent allows for the quantification of both the amount of antigen bound by a B cell (by direct measurement of cell-associated Alexa Fluor 647 fluorescence) and of MHC class II presentation (by staining with peptide-MHC \[pMHC\]--specific antibody Y-Ae; Fig. S3 B; [@bib41]). To measure the influence of competition on antigen capture, we transferred B1-8^lo^ cells into MD4 hosts in the presence or absence of B1-8^hi^ B cells or into WT hosts and immunized recipients with NP-Eα in alum. B cell--associated antigen and antigen presentation on MHC II were measured 16 h later by flow cytometry ([Fig. 3 A](#fig3){ref-type="fig"}). A similar proportion of B1-8^lo^ B cells (∼50%) bound and presented similar amounts of antigen, regardless of the presence or absence of B1-8^hi^ B cells or of recipient host (WT vs. MD4; [Fig. 3, B and C](#fig3){ref-type="fig"}). Thus, the amount of antigen captured and presented by low-affinity B cells is not altered by competition with high-affinity cells but instead shows a remarkable correlation with BCR affinity. B1-8^hi^ cells, whose BCRs have a 40-fold higher affinity to NP than those of B1-8^lo^ cells, show a two- to threefold higher level of antigen uptake and a three- to fourfold higher level of pMHC presentation when compared with their lower-affinity counterparts ([Fig. 3, B and C](#fig3){ref-type="fig"}). Most importantly, even though their proliferation at later time points is severely impaired, B1-8^lo^ B cells capture, process, and present on MHC II the same amount of antigen, irrespective of the presence of competing B cells. We conclude that, under the conditions tested, competition for antigen acquisition or for BCR-delivered signals does not play a limiting role in pre-GC expansion.

![**Competition does not affect antigen binding and presentation by low-affinity B cells.** (A) Diagrammatic representation of the experimental protocol. (B, left) Flow cytometric analysis of antigen binding by B1-8^hi^ and B1-8^lo^ cells under different transfer conditions. Gated as CD19^+^Igλ^+^CD45.1^+^ (B1-8^hi^) or CD19^+^Igλ^+^CFP^+^ (B1-8^lo^). (right) Quantification of flow cytometry data. (C, left) Flow cytometric analysis of antigen presentation by B1-8^hi^ and B1-8^lo^ cells under different transfer conditions. Cell types are gated as in B; only Alexa Fluor 647^+^ cells are plotted. The Y-Ae antibody binds to the I-Eα~52--68~ peptide in the context of I-A^b^. (right) Quantification of flow cytometry data. Each symbol represents one mouse. Data are from two independent experiments with two mice per condition per experiment.](JEM_20102477_GS_Fig3){#fig3}

Additionally, we tested whether antigen dose is limiting for B cell proliferation and activation by conducting antigen titration experiments in MD4 mice receiving B1-8^lo^ cells or 1:1 mixtures of B1-8^lo^ and B1-8^hi^ B cells. Mice were immunized with 5, 50, or 200 µg of antigen, and B cell activation and proliferation were measured by flow cytometry ([Fig. 4 A](#fig4){ref-type="fig"}). Surprisingly, proliferation and activation of B1-8^lo^ B cells was always decreased to approximately half in the presence of cotransferred B1-8^hi^ B cells, regardless of antigen dose ([Fig. 4, B and C](#fig4){ref-type="fig"}). Thus, although the extent of cell division and activation is dependent on the concentration of antigen, competition between antigen-specific B cells is not, and affinity-dependent competition between pre-GC B cells is detectable over a wide range of antigen doses.

![**Inhibition of proliferation/activation by competition is independent of antigen dose.** (A) Diagrammatic representation of the experimental protocol. (B) Flow cytometric analysis of transferred B1-8^lo^ CD45.1^+^ CFSE-labeled B cells in draining lymph nodes 4 d after immunization. Gated on CD19^+^Igλ^+^CD45.1^+^. (top) Representative FAS/GL-7 plots. (bottom) Representative CFSE histogram. (C) Quantification of data in B. Each symbol represents one mouse. Data are from two independent experiments with two to three mice per condition per experiment.](JEM_20102477_GS_Fig4){#fig4}

Increased access to T cell help provides a competitive advantage to pre-GC B cells
----------------------------------------------------------------------------------

Even if access to, uptake, and presentation of antigen remain unaltered by competition, the observed inhibition of B1-8^lo^ cell activation and proliferation could still be mediated by the availability of T cell help. In this model, a limiting number of helper T cells would interact preferentially with pre-GC B cells presenting the highest density of cognate pMHC at the T--B border stage, as was shown to occur in the GC ([@bib50]). To test this idea, we first examined the effect on pre-GC competition of increasing the amount of antigen-specific T cells. To this end, we transferred an equal number of B1-8^lo^ and B1-8^hi^ Igλ^+^ B cells along with either 2 × 10^5^ or 2 × 10^6^ OT-II T cells and measured B cell proliferation and activation at day 4 after immunization ([Fig. S4](http://www.jem.org/cgi/content/full/jem.20102477/DC1)). Increasing the number of antigen-specific T cells led to an overall increase in both B1-8^hi^ and B1-8^lo^ proliferation and activation, indicating that T cell help is indeed limiting at this early stage. Furthermore, there was a slight decrease in the effect of B1-8^hi^ competition on B1-8^lo^ proliferation/activation, suggesting that the availability of T cell help could also play a role in pre-GC competition.

To test this hypothesis under more controlled conditions, we delivered antigen to B cells without cross-linking surface Ig by targeting it directly to cells that express DEC205 using a chimeric anti-DEC205 antibody fused to OVA (α-DEC205--OVA; [@bib4]). Activated B cells expressed low levels of DEC205, a cell surface lectin that efficiently delivers antigen to the MHC II processing compartment ([Fig. S5 A](http://www.jem.org/cgi/content/full/jem.20102477/DC1); [@bib18]; [@bib20]). Chimeric antibodies to this receptor, linked to protein antigens such as OVA, target these antigens to DEC205-expressing APCs, including B cells and dendritic cells. To examine the impact of increased pMHC on proliferation and activation, we cotransferred allotype-marked B1-8^hi^ B cells that were either DEC205 deficient or sufficient (DEC205^−/−^ or DEC205^+/+^), along with OVA-specific OT-II T cells, into DEC205^−/−^ hosts. Recipient mice were then immunized with NP-OVA and treated with α-DEC205--OVA, PBS, or a control chimeric DEC205 antibody carrying an irrelevant antigen, *Plasmodium falciparum* circumsporozoite protein (α-DEC205--CS; [@bib5]), to exclude an effect of DEC205 receptor ligation on B cell activation ([Fig. 5 A](#fig5){ref-type="fig"}). DEC205^+/+^ and DEC205^−/−^ B1-8^hi^ pre-GC B cells showed similar levels of proliferation and activation in mice treated with PBS or α-DEC205--CS. Approximately 76% of cells in both populations were CFSE^low^, and 34% were GL-7^+^ and FAS^+^ ([Fig. 5 B](#fig5){ref-type="fig"}). In contrast, when mice received α-DEC205--OVA, the DEC205^+/+^ B1-8^hi^ population outcompeted the DEC205^−/−^ B1-8^hi^ B cells in terms of both proliferation and activation. Proliferation by DEC205^+/+^ B cells, as measured by CFSE dilution, increased from 76 to 89%, and the percentage of activated B cells doubled to 68%. Most importantly, the DEC205^−/−^ B1-8^hi^ B cells displayed a lower level of proliferation (60 vs. 76%) and activation (17 vs. 34%) when compared with mice receiving either the control antibody α-DEC205--CS or PBS, despite receiving similar amounts of NP-OVA antigen ([Fig. 5 C](#fig5){ref-type="fig"}). To test whether increasing T cell help alone could compensate for the large difference in affinity between B1-8^hi^ and B1-8^lo^ B cells, we cotransferred a 1:1 mixture of B1-8^lo^, DEC205^+/+^, and B1-8^hi^ DEC205^−/−^ Igλ^+^ B cells, along with OT-II T cells, into DEC205^−/−^ MD4 recipients and immunized these hosts with NP-OVA (Fig. S5, B and C). When recipients were treated with PBS or control α-DEC205--CS after immunization, B1-8^lo^ proliferation/activation was substantially lower than that of B1-8^hi^ cells. Treatment with α-DEC205--OVA was capable of restoring B1-8^lo^ proliferation/activation to near B1-8^hi^ levels in 3/5 mice (Fig. S5 C).

![**Access to T cell help drives early B cell competition.** (A) Diagrammatic representation of the experimental protocol. (B) Flow cytometric analysis of transferred B1-8^hi^DEC205^+/+^CFP^+^ and B1-8^hi^DEC205^−/−^CD45.1^+^ CFSE-labeled B cells in draining lymph nodes 4 d after immunization. Gated on CD19^+^Igλ^+^CD45.1^+^ (B1-8^hi^DEC205^+/+^) or CD19^+^Igλ^+^CFP^+^ (B1-8^hi^DEC205^+/+^) cells. (top) Representative CFSE dilution profile. (bottom) Representative FAS/GL-7 plot. (C) Quantification of data in B. Each symbol represents one mouse. Data are from three independent experiments with one to two mice per condition per experiment. CS, *P. falciparum* circumsporozoite protein (used as a control antigen).](JEM_20102477_LW_Fig5){#fig5}

To determine whether the competitive advantage in proliferation and activation provided by increased T cell help is associated with increased GC occupancy, we examined the composition of GCs produced under the same conditions 6 d after immunization ([Fig. 6 A](#fig6){ref-type="fig"}). Whereas GCs in mice treated with anti-DEC205--CS or PBS were composed of nearly equal numbers of DEC205^+/+^ and DEC205^−/−^ B cells, treatment with anti-DEC205--OVA resulted in GCs that were almost exclusively filled with DEC205^+/+^ B1-8^hi^ B cells ([Fig. 6, B and C](#fig6){ref-type="fig"}). We conclude that increasing the density of pMHC on the B cell surface is sufficient to provide a competitive advantage to pre-GC B cells in conditions of equal BCR cross-linking.

![**Increased T cell help drives greater GC occupancy and plasmablast differentiation.** (A) Diagrammatic representation of the experimental protocol. (B) Flow cytometric analysis of transferred B1-8^hi^DEC205^+/+^CFP^+^ and B1-8^hi^DEC205^−/−^CD45.1^+^ B cells in draining lymph nodes 6 d after immunization. (top) GC occupancy. Gated on CD19^+^Igλ^+^GL-7^+^FAS^+^. (bottom) Composition of plasmablast compartment. Gated on CD138^hi^B220^int^. (C) Quantification of data in B. Each symbol represents one mouse. Data are from three independent experiments with one to two mice per condition per experiment. CS, *P. falciparum* circumsporozoite protein (used as a control antigen).](JEM_20102477_GS_Fig6){#fig6}

B cells with higher pMHC density monopolize T cell help in T--B border clusters
-------------------------------------------------------------------------------

To directly test the idea that increased antigen presentation leads to enhanced T cell interaction and to verify that T cell signals are limiting during the pre-GC stage, we set out to observe the interactions between T cells and B1-8^hi^ B cells by multiphoton laser-scanning microscopy of lymph nodes in living mice. To this end, we transferred CFP-expressing DEC205^+/+^, GFP-expressing DEC205^−/−^ B1-8^hi^ B cells, and dsRed-expressing OT-II T cells into DEC205^−/−^ recipients. Mice were then immunized with NP-OVA and treated with α-DEC205--OVA or control α-DEC205--CS. In vivo imaging of the T and B cell clusters at the T--B border in popliteal lymph nodes was performed 36--48 h after immunization ([Fig. 7 A](#fig7){ref-type="fig"}). Long-lasting (\>10 min) motile T--B cell interactions, indicative of active T cell help ([@bib29]), were counted ([Fig. 7 B](#fig7){ref-type="fig"} and [Videos 1 and 2](http://www.jem.org/cgi/content/full/jem.20102477/DC1)). In control mice treated with α-DEC205--CS, we found similar frequencies of long-lasting motile conjugates between OT-II cells and B1-8^hi^ DEC205^+/+^ and DEC205^−/−^ B cells ([Fig. 7, B and C](#fig7){ref-type="fig"}; and Video 1). In contrast, in mice treated with α-DEC205--OVA, 90% of all specific T--B cell interactions were between OT-II T cells and DEC205^+/+^ B1-8^hi^ B cells ([Fig. 7 C](#fig7){ref-type="fig"} and Video 2). We conclude that T cell signals are limiting for affinity selection of pre-GC B cells and that T cells preferentially interact with B cells with a higher density of surface pMHC.

![**B cells with higher surface MHC preferentially interact with cognate T cells at the T--B border.** (A) Diagrammatic representation of the experimental protocol. (B) Collapsed z stacks of three-dimensional image series of T--B border clusters in living mice. Arrowheads indicate long-lasting conjugates (\>10 min) between OT-II T cells (red) and either B1-8^hi^DEC205^+/+^ (green) or B1-8^hi^DEC205^−/−^ (cyan) B cells. (C) Quantification of T--B cell interactions in intravital videos. Pie charts represent the proportion of long-lasting T--B conjugates involving DEC205^+/+^ and DEC205^−/−^ B1-8^hi^ B cells. The total number of conjugates analyzed is indicated in the center of each chart. The charts represent pooled data from multiple videos taken from three independent experiments, one mouse per condition per experiment. CS, *P. falciparum* circumsporozoite protein (used as a control antigen).](JEM_20102477_RGB_Fig7){#fig7}

DISCUSSION
==========

GCs are seeded by a small number of precursor clones that expand, mutate, and undergo affinity-dependent selection ([@bib23]; [@bib17]; [@bib25]). GC selection plays a major role in limiting clonal diversity and is regulated in large part by follicular helper T cells ([@bib50]). Less is known about the role of affinity in the initial events that lead to GC formation. B cells are activated to enter the GC reaction by BCR cross-linking in the B cell follicle, at the lining of the subcapsulary sinus, or while migrating through the T cell area ([@bib35]; [@bib6]; [@bib19]; [@bib34]; [@bib49]). Signals from the BCR direct activated B cells to the T--B border, where they can encounter cognate T cells ([@bib12]; [@bib29]). Although only B cells specific for the immunizing antigen are thought to relocate to the T--B border, B cells with very low affinity for NP, such as B1-8^lo^ B cells, with a *K*~a~ of 1.25 × 10^5^ M^−1^ and *K*~d~ of 8 × 10^−6^ M, and T1(V23)µ^a^ cells, whose affinity is too low to reliably measure, are still capable of forming GCs ([@bib8]; [@bib47]). In addition, the artificially reverted germline versions of naturally occurring high-affinity, somatically mutated antibodies to antigens such as HIV show very low affinities to antigen ([@bib43]; [@bib27]). Thus, the absolute affinity threshold for the initial event that triggers the B cell GC program must be very low. In this study, we address the question of how GC founder B cells are selected from among the relatively large number of naive B cells intrinsically capable of passing this low BCR-dependent activation threshold.

We show evidence for an affinity-dependent checkpoint operating within clusters of B and T cells that form at the T--B border within 1--2 d of immunization. Our data show that competition from higher-affinity B cells impairs the ability of lower-affinity B cells to become activated, proliferate, and eventually reach an intermediary pre-GC stage characterized by up-regulation of FAS, GL-7, and CCR6. Although these findings do not argue against the existence of a threshold affinity for B cell activation, they indicate that additional layers exist that restrict the breadth of the early B cell response.

Our antigen acquisition and processing data suggest that competition does not limit access to antigen delivered subcutaneously in alum. High-affinity B cells acquire more antigen than low-affinity cells, but the presence of the former has no measurable effect on antigen acquisition by the latter. In addition, pre-GC competition is comparable across a range of different antigen concentrations, which also argues against a model in which B cells compete for relative access to antigen. However, our experiments do not rule out the possibility of competition for antigen acquisition under other conditions, such as when small amounts of antigen are delivered by direct transfer from other cells ([@bib35]; [@bib6]; [@bib19]; [@bib34]; [@bib49]; [@bib13]). Thus, it remains possible that direct competition for access to antigen would provide an additional checkpoint to prevent B cells with relatively lower affinities for antigen from entering the GC.

Within GCs, B cells compete for T cell help. B cells with high-affinity BCRs residing in the light zone of the GC capture more antigen and present a higher level of cognate pMHC on their surfaces than low-affinity cells. Follicular helper T cells interact preferentially with the B cells presenting the highest levels of pMHC and induce them to move to the dark zone where they undergo proliferative expansion ([@bib50]). Similarly, the absence of H2-O, an MHC family molecule that inhibits peptide presentation, confers a competitive advantage to GC B cells ([@bib9]), and increased T cell help in Roquin-deficient or Qa-1(D227K) mice leads to inappropriate GC B cell activation and autoimmunity ([@bib52]; [@bib21]). Our data show that T cell help is also essential for affinity-dependent B cell selection at the T--B border. As in the GC, T--B border T cells mediate selection by distinguishing among B cells on the basis of the amount of cognate pMHC presented. Artificially increasing pMHC on high-affinity cells through DEC205 targeting of antigen had a dramatic effect on T--B border competition, GC seeding, and plasma cell differentiation. However, the same approach was capable of rescuing the proliferation of low-affinity cells in only 3/5 recipients (Fig. S5, B and C). Although the reasons for such variability are unclear, it may indicate the existence of further checkpoints to the progression of B1-8^lo^ cells into a productive GC response, perhaps even at the level of antigen binding. However, technical issues, such as an inability to increase pMHC levels on B1-8^lo^ cells to a level higher than that presented by the DEC205^−/−^ B1-8^hi^ cells, cannot be discounted.

Although B cells in pre-GC T--B border clusters can be distinguished from GC B cells by microanatomic location and cell surface markers (Fig. S2), the two cell types share certain characteristics such as brisk proliferation, activated B cell morphology, and engagement in motile contacts with helper T cells ([@bib29]). One important difference between such B cells in T--B border clusters and GC cells is the duration of T--B conjugates, which are much longer-lived in T--B border clusters ([@bib29]; [@bib1]; [@bib11]). These long-lived contacts provide the ideal setting for T cell--mediated selection. Our experiments show that higher-affinity B cells with higher cognate pMHC surface densities monopolize T cell help, physically interfering with a T cell's ability to interact with low-affinity B cells. The data suggest a dynamic mechanism that accounts for pre-GC competition in which BCR affinity serves as a determinant of the amount of peptide presented on the B cell surface; B cells with higher pMHC densities would compete favorably for access to helper T cells, leading to the proliferation of higher-affinity B cells and to the gradual elimination of lower-affinity cells from the reaction.

The GC reaction is critical to the production of high-affinity antibodies because it is the microanatomic location wherein B cells express activation-induced cytidine deaminase (AID; [@bib28]). Although AID has a strong preference for Ig genes, it also produces mutations in bystander oncogenes such as Bcl6 ([@bib31]; [@bib46]), and it is responsible for initiating chromosome translocations such as those between c-myc and IgH, which produce Burkitt's lymphoma and plasmacytoma ([@bib39], [@bib40]). One clear advantage of an affinity-based pre-GC checkpoint is the economy of resources provided by limiting the number of B cell clones undergoing the GC reaction; an additional advantage is limiting the number of clones exposed to AID. In contrast, the ability to engage low-affinity clones and the low threshold for B cell activation in vivo is likely to be essential to ensuring that there will be an initial response to antigen, irrespective of B cell precursor frequency or initial affinity. Early competition before the GC prevents the costly expansion of a substantial number of low-affinity clones. A potential disadvantage to limiting the number of clones that participate in GC responses is the emergence of immunodominant epitopes, which may be exploited by pathogens to direct antibodies away from neutralizing epitopes. This seems to be the case with influenza, where the generation of antibodies to broadly neutralizing epitopes on the hemagglutinin stem seems to be prevented by competition from more "attractive" epitopes on the protein head ([@bib10]), and may also be the case in HIV infection ([@bib43]). Thus, the evolution of a pre-GC affinity-dependent selection checkpoint may have been shaped by the need to produce high-affinity antibodies to pathogens while preventing excessive exposure to AID-induced mutagenesis.

MATERIALS AND METHODS
=====================

### Mice.

C57BL/6 (WT), B6.SJL (CD45.1^+^), and mice transgenic for GFP ([@bib42]), CFP ([@bib16]), and dsRed ([@bib51]) were purchased from the Jackson Laboratory. MD4 BCR-transgenic ([@bib14]) and OT-II TCR-transgenic ([@bib3]) mice were maintained at the Rockefeller University. B1-8^hi^ and B1-8^lo^ IgH knockin ([@bib48]) and DEC205^−/−^ mice ([@bib15]) were generated and maintained in our laboratory. All mice were on a C57BL/6 background. For adoptive transfer experiments, donor mice were 8--16 wk and recipients were 6--10 wk of age. Mice were housed under specific pathogen-free conditions. The animal protocol was approved by the Rockefeller University.

### Cell transfer, immunization, and antigens.

B cells were purified by immunomagnetic depletion with anti-CD43 beads (Miltenyi Biotec). For flow cytometry experiments, 5 × 10^6^ B1-8^hi^ total B cells (5 × 10^5^ B1-8^hi^ NP-specific Igλ^+^ B cells) and 15 × 10^6^ B1-8^lo^ total B cells (5 × 10^5^ B1-8^lo^ NP-specific Igλ^+^ B cells) were transferred intravenously before immunization. For histology and in vivo imaging, NP-specific B cells were further enriched by depletion of Igκ^+^ cells using anti--Igκ-PE (BD) followed by anti-PE beads (Miltenyi Biotec). For in vivo imaging, 4 × 10^5^ Igλ^+^ B1-8^hi^ DEC205^+/+^ and 4 × 10^5^ Igλ^+^ B1-8^hi^ DEC205^−/−^ B cells were transferred. OT-II T cells were purified by immunomagnetic depletion with a CD4^+^ T cell isolation kit (Miltenyi Biotec). 2 × 10^5^ OT-II T cells were cotransferred along with the B cells in all experiments involving B cell activation or proliferation. 1 d after B cell transfer, mice were immunized with NP~3~-OVA precipitated in alum (2:1). Mice were injected subcutaneously with 8 µg NP~3~-OVA per footpad and 16 µg into the base of the tail. For antigen pick-up and presentation experiments, mice were immunized with 5 µg NP-Eα precipitated in alum (2:1) in both hind footpads. For NP-PE binding experiments, mice were injected subcutaneously with 8 µg NP~25~-PE (Biosearch Technologies) per footpad and 16 µg into the base of the tail. For targeting of antigens via DEC205, mice were injected subcutaneously with α-DEC205--OVA or α-DEC205--CS into each hind footpad at the dose indicated in each figure.

### Production of the NP-Eα regent.

NP succinimidyl ester (Biosearch Technologies) was conjugated to either purified SA (ProZyme) or SA--Alexa Fluor 647 (Invitrogen) to a hapten to protein ratio of ∼10. This conjugate was then incubated with sixfold molar excess of biotinylated Eα~52--73~ peptide preceded by a flexible Gly-Ser-Gly linker (full sequence, biotin-GSGFAKFASFEAQGALANIAVDKA-COOH), and free peptide was removed by dialysis. Nonhaptenylated SA and SA--Alexa Fluor 647 were also bound to biotinylated peptide as a control. For testing purposes, purified splenic B1-8^hi^ B cells were incubated in complete RPMI with 10% FCS supplemented with 1 µg/ml NP-Eα or control reagents for 18 h at 37°C and 5% CO~2~. Surface pMHC expression was detected by flow cytometry using the Y-Ae antibody.

### Flow cytometry.

Lymph nodes were forced through a 70-µm mesh into PBS supplemented with 2% fetal calf serum and 1 mM EDTA. Single-cell suspensions were incubated for 5 min with 1 µg/ml anti-CD16/32 (24G2; eBioscience) and then stained for 30 min at 4°C using the antibodies indicated in [Table S1](http://www.jem.org/cgi/content/full/jem.20102477/DC1). Samples were acquired using a flow cytometer (LSRII; BD). Data were analyzed using FlowJo version 8 software (Tree Star) for Macintosh.

### Immunofluorescence.

Cryostat sections of lymph nodes were fixed and stained as described previously ([@bib24]). In brief, organs were fixed in PBS with 4% paraformaldehyde and 10% sucrose and cryoprotected in PBS with 30% sucrose before being embedded in OCT compound (Sakura) and frozen. Frozen lymph nodes were sectioned (20-µm thickness) on a microtome and fixed in acetone. For immunostaining, all incubations were performed in a humidified chamber at room temperature. Sections were blocked in 5% BSA, 10% goat serum, and sequentially with excess SA and biotin (Vector Laboratories). The following antibodies were used for staining: anti-IgD--Alexa Fluor 647 (eBioscience), anti--CD45.1-PE (BD), CD35-biotin (BD), and SA-Cy3 (Jackson ImmunoResearch Laboratories, Inc.).

### Confocal microscopy.

Confocal images were acquired on an LSM 510 system (Carl Zeiss) with 488-, 543-, and 633-nm excitation lines at the Rockefeller University Bio-Imaging Resource Center. Z-stack (three planes, 3-µm z steps) images were obtained with a Plan-Apochromat 20× NA 0.75 air objective. Images were acquired using LSM software (Carl Zeiss) and processed for presentation using Photoshop CS4 (Adobe).

### Multiphoton laser-scanning microscopy.

Multiphoton imaging of popliteal lymph nodes was performed as described previously ([@bib50]). In brief, mice were anaesthetized with 100 mg ketamine, 15 mg xylazine, and 2.5 mg acepromazine per kg body weight and were kept anaesthetized by inhalation of 1.25% isoflurane in 100% oxygen. The hind legs of mice were shaved, and mice were restrained on a stage warmer at 37°C (BioTherm Micro S37; Biogenics). The lymph node was exposed through an incision made on the hind leg and held in position using a metal strap with a small opening through which the node was imaged. Images were acquired at the Rockefeller University Bio-Imaging Resource Center using an upright microscope (BX61 with 25× NA 1.05 Plan water-immersion objective; Olympus) fitted with a laser (Chameleon Vision II; Coherent) tuned to 910 nm. Fluorescent emission was detected using a pair of overlapping CFP (460--510) and GFP (495--540) filters, separated by a 505 dichroic mirror, and a third filter (575--630) for the dsRed signal. For three-dimensional time series, we acquired 40-µm-deep z stacks with 5-µm z resolution, with an x--y resolution of 320 × 320 pixels and 1 µm/pixel, and a time resolution of 40 s/frame. Images were acquired using FluoView F1000 software (Olympus).

### Intravital image analysis.

Intravital 4D datasets were analyzed using Volocity software version 5.0 (PerkinElmer). For the quantification of T cell--B cell contacts, all OT-II T cells were manually inspected for interactions with B1-8^hi^ B cells of either genotype. Only long-lasting (\>10 min), motile interactions in which B cells were leading the path of displacement were scored as T--B conjugates. Images were processed for presentation using Photoshop CS4. Videos were processed for presentation using After Effects version 8.0 (Adobe).

### Statistical analysis.

Multiple group comparisons were performed by analysis of variance with Tukey's post test. Intravital imaging quantification was performed by Fisher's exact test. All analyses were performed using Prism version 5.0b (GraphPad Software).

### Online supplemental material.

Fig. S1 shows a comparison of NP-PE--binding naive B cells in WT and MD4 mice. Fig. S2 shows the kinetics of appearance of histologically detectable GCs and of expression of GC-associated markers. Fig. S3 shows the in vitro characterization of the NP-Eα reagent. Fig. S4 shows DEC205 expression by flow cytometry on naive and GC B cells. Fig. S5 shows antigen delivery to B cells via DEC205. Videos 1 and 2 show multiphoton intravital time series of T cell--B cell interactions in T--B border clusters after treatment with α-DEC205--CS or α-DEC205--OVA, respectively. Table S1 lists the antibodies used for flow cytometry staining. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20102477/DC1>.

This work was supported in part by National Institutes of Health (NIH) grants R01 AI072529 (to M.C. Nussenzweig and M.L. Dustin) and R01 AI055037 (to M.L. Dustin). T.A. Schwickert was supported by the Schering foundation. D.R. Fooksman was supported by NIH training grant CA009161-34. M.C. Nussenzweig is a Howard Hughes Medical Institute Investigator. Support for the Rockefeller University multiphoton microscope was granted by the Empire State Stem Cell Fund through New York State Department of Health (NYSDOH) contract \#C023046. Opinions expressed in this paper are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Fund, the NYSDOH, or the State of New York.

The authors have no financial conflicts of interest.

Abbreviations used:AIDactivation-induced cytidine deaminaseGCgerminal centerNP4-hydroxy-3-nitrophenylacetylpMHCpeptide-MHCSAstreptavidin

[^1]: T.A. Schwickert and G.D. Victora contributed equally to this paper.
